For in vivo studies we used db/db type 2 diabetes mice as a model of DKD and Col4a3-/- mice as an experimental Alport syndrome model to determine presence and activity of the cGAS-STING pathway in the kidneys. Here, CGAS is linked to Alport syndrome.